Alnylam Pharmaceuticals | ALNY - Ebit





Ebit Veränderung Datum
Acadia Pharmaceuticals USD 71.72M 33.88M 2026-09
Agios Pharmaceuticals USD -110.55M 527K 2026-06
Alnylam Pharmaceuticals USD 179.66M 67.06M 2026-09
Amgen USD 4.68B 65M 2026-09
Arrowhead Research USD -154.34M 13.08M 2026-06
BioCryst Pharmaceuticals USD 98.46M 161.92M 2026-06
BioMarin Pharmaceutical USD 205.6M 100M 2026-09
Incyte USD -707.47M 1.41B 2026-09
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
Moderna USD 130M 945M 2026-09
Neurocrine Biosciences USD 343M 123.1M 2026-09
Novartis USD 1.78B 2.4B 2026-09
PTC Therapeutics USD 146.03M 100.14M 2026-06
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Sanofi EUR 1.12B 1.06B 2026-06
Sarepta Therapeutics USD -9.04M 22.33M 2026-09
Takeda JPY 205.32B 3.9B 2026-09
Tectonic Therapeutic USD -24.22M 3.08M 2026-06
Ultragenyx Pharmaceutical USD -110M 35M 2026-09
Vertex Pharmaceuticals USD 1.26B 11.3M 2026-09
Xencor USD -36.6M 41.26M 2026-06